Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

9.15
Delayed Data
As of Jan 13
 -0.04 / -0.44%
Today’s Change
7.12
Today|||52-Week Range
12.15
-1.61%
Year-to-Date
It's Full Speed Ahead for Opko Health After Pipeline Stumble
Jan 12 / MotleyFool.com - Paid Partner Content
What's Next for Opko Health After Its Recent Clinical Setback?
Jan 04 / MotleyFool.com - Paid Partner Content
How a Bust Caused Opko Health Shares to Tumble in 2016
Jan 10 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Inotek Plunges on Pipeline Setback, Kite Files IND for Study I...
Jan 04 / Zacks.com - Paid Partner Content
Weekly CEO Buys Highlights
Jan 09 / GuruFocus News - Paid Partner Content
OPKO Health (OPK) Reports Failure in hGH-CTP Phase 3
Jan 02 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close9.19
Today’s open9.20
Day’s range9.11 - 9.30
Volume2,670,840
Average volume (3 months)4,246,978
Market cap$5.1B
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+85.37%
Earnings growth (this year)-26.67%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+439.63%
P/E ratioNM
Price/Sales9.97
Price/Book2.52

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...-0.30-1.92%
MNKMallinckrodt Plc-0.98-1.90%
GRFSGrifols SA+0.25+1.50%
IONSIonis Pharmaceutical...-1.45-2.93%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$491.7M
Annual profit (last year)-$30.0M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
CFO, Treasurer, &
Chief Accounting Officer
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts


Search for Jobs